Investors hope psychedelics are the new cannabis. Are they high?

October 19, 2019 Articles 7:21 pm

Christian angermayer has never drunk alcohol nor smoked a cigarette. He is, however, a fan of ketamine. In January atai Life Sciences, the German biotech company he founded last year, acquired a majority stake in Perception Neuroscience, a biopharmaceutical firm from New York which is developing a medication for pyschiatric conditions like depression from the drug, which is illegal in parts of the world (though not in America).

 

JOIN THE ATAI #INSIGHTNETWORK

Receive the latest news on ATAI and innovations in the space.

Email
submit